Skip to main content

Table 2 Factors associated with IPT uptake

From: Factors affecting uptake and completion of isoniazid preventive therapy among HIV-infected children at a national referral hospital, Kenya: a mixed quantitative and qualitative study

Variable IPT uptake PR (95% CI) P Value
Yes (N = 152) n (%) No (N = 73) n (%)
Gender
 Male 85 (65.0) 33 (35.0) 1.15(0.95–1.38) 0.136
 Female 67(62.0) 40 (38.0) 1
Age categories
  < 3 years 8 (36.0) 14 (64.0) 1
 Between 3- > 5 years 14 (45.0) 17 (55.0) 1.24 (0.63–2.44) 0.539
 5- < 10 years 121 (70.0) 52 (30.0) 1.92 (1.09–3.37) 0.003
Latest viral load
 Virally suppressed 128 (71.0) 53 (29.0) 1.06 (0.80–1.41) 0.663
 Not suppressed 18 (67.0) 9 (33.0) 1
 Not documented 6 (35.0) 11 (65.0)
History of TB treatment
 Yes 15 (60.0) 10 (40.0) 1
 No 137 (69.0) 63 (31.0) 1.14 (0.82–1.59) 0.401
Baseline WHO HIV staging
 1 65 (73.9) 23 (26.1) 1
 2 38 (60.3) 25 (39.7) 0.81 (0.64–1.03) 0.083
 3 35 (74.5) 12 (25.5) 1.01 (0.82–1.24) 0.948
 4 6 (50.0) 6 (50.0) 1.4 (0.29–6.8) 0.67
 Not documented 8 (53.3) 7 (46.7)